Brian Cole, M.D., a sports medicine physician at Midwest Orthopaedics at Rush (MOR), has been named an Honorary Member of the National Athletic Trainers Association (NATA). Dr. Cole, head team physician for the Chicago Bulls, is the only physician recipient this year. He follows two other MOR sports medicine leaders who were past recipients: Drs. Bernard Bach (2009) and Charles Bush-Joseph (2015).
Brian Cole, M.D. Receives Honorary Membership From NATA
1 min read Premium comments
According to the February 8, 2017 news release, “The Honorary Membership is awarded annually to individuals who have shown profound interest in and have provided significant contributions to the profession of athletic training. According to NATA leadership, honorees display a dedication to advancing, promoting and championing the efforts of the association and its members. Dr. Cole will receive the honor at the 68th Clinical Symposia & AT Expo in Houston, June 26 – 29. For more than 20 years, Dr. Cole has been dedicated to providing quality orthopedic care to pro, collegiate, youth and recreational athletes. In 2009, Dr. Cole was selected NBA team physician of the year. In addition to his medical responsibilities with the Bulls, he serves as associate team physician for the Chicago White Sox and DePaul University. He is also a professor in the Department of Orthopedics with an appointment in Anatomy and Cell Biology and Section Head of the Cartilage Research and Restoration Center at Rush University Medical Center (RUMC), Sports lovers can tune into ESPN Radio Saturday mornings to hear Dr. Cole as co-host on ‘Sports Medicine Weekly.’”
Dr. Cole told OTW, “Because of the tremendous role that our ATCs [certified athletic trainer] have in the comprehensive management of our teams and organizations, this honor is even more special to me. It is humbling especially given the number of other qualified orthopedic surgeons who also continue to contribute to the NATA in meaningful ways.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.